Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKudryavtsev, K. V.-
dc.contributor.authorKorokin, M. V.-
dc.contributor.authorGudyrev, O. S.-
dc.identifier.citationKudryavtsev, K.V. Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction / K. V. Kudryavtsev, M. V. Korokin, O. S. Gudyrev // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol. 3, № 1.- P. 10-17. - Doi: 10.18413/2500-235X-2017-3-1-10-17. - Refer.: p.
dc.description.abstractThe study of endotelio- and cardioprotective activity of finished dosage forms - tablets, film-coated, containing 10 mg of phenolic nature KUD-975, was shown a statistically significant decrease in blood pressure and the coefficient of endothelial dysfunction on the background of simulation L-NAME-induced pathology. In the group of animals treated with KUD975 found a statistically significant increase in the concentrations of stable metabolites of nitric oxide, which in addition to the normalization of vasodilation says about endothelioprotektive action of the compounds studiedru
dc.subjectendothelial dysfunctionru
dc.subjectarginase inhibitorsru
dc.subjectcompounds of phenolic natureru
dc.titlePharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunctionru
Appears in Collections:Vol. 3, № 1

Files in This Item:
File Description SizeFormat 
Kudryavtsev_Pharmacologocal_17.pdf805.56 kBAdobe PDFView/Open
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.